Source comparison
Evening vs Morning Administration — What the Data Shows
The majority of published protocols using GHRH-ghrelin mimetic combinations favour evening administration 30–60 minutes before sleep. A 2019 study in the Journal of Clinical Endocrinology & Metabolism compared identical doses of combined GHRH + ghrelin recepto
This comparison does not assign a generated winner or score.
- The majority of published protocols using GHRH-ghrelin mimetic combinations favour evening administration 30–60 minutes before sleep. A 2019 study in the Journal of Clinical Endocrinology & Metabolism compared identical doses of combined GHRH + ghrelin receptor agonists given at 08:00 vs 22:00 and found that evening dosing produced mean peak GH concentrations 1.8× higher than morning dosing. The mechanism: sleep-stage architecture amplifies the secretagogue effect through suppression of hypothalamic somatostatin neurons during slow-wave sleep.
- Morning administration still works. It just works differently. When Tesamorelin + Ipamorelin is given immediately upon waking (before food, before exercise), it creates a sharp GH pulse that overlays the natural cortisol awakening response. This doesn't produce the same sustained elevation as evening dosing, but it avoids one significant trade-off: sleep disruption. Approximately 15–20% of individuals report difficulty initiating or maintaining sleep when GH secretagogues are administered within 90 minutes of bedtime. The proposed mechanism is activation of the sympathetic nervous system via ghrelin's orexigenic (appetite-stimulating) pathway, which can delay sleep onset in ghrelin-sensitive individuals.
- Our experience across research protocols: evening administration delivers higher integrated GH output in the majority of cases, but morning administration is the better choice for individuals who experience insomnia, vivid dreams, or night sweats on evening dosing. There is no universal 'best' time. There is a physiological preference (evening) and a tolerance-based alternative (morning). Both produce measurable IGF-1 elevation when administered on an empty stomach.